143 related articles for article (PubMed ID: 23276469)
1. Biomarkers and electrocardiographic evidence of myocardial ischemia in patients with human immunodeficiency virus infection.
Gupta M; Miller CJ; Baker JV; Lazar J; Bogner JR; Calmy A; Soliman EZ; Neaton JD;
Am J Cardiol; 2013 Mar; 111(5):760-4. PubMed ID: 23276469
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller LH; Tracy R; Belloso W; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Neuhaus J; Nixon D; Paton NI; Neaton JD;
PLoS Med; 2008 Oct; 5(10):e203. PubMed ID: 18942885
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.
Porter BO; Shen J; Kovacs JA; Davey RT; Rehm C; Lozier J; Csako G; Nghiem K; Costello R; Lane HC; Sereti I
AIDS; 2009 Sep; 23(15):2015-9. PubMed ID: 19617815
[TBL] [Abstract][Full Text] [Related]
4. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.
Neuhaus J; Jacobs DR; Baker JV; Calmy A; Duprez D; La Rosa A; Kuller LH; Pett SL; Ristola M; Ross MJ; Shlipak MG; Tracy R; Neaton JD
J Infect Dis; 2010 Jun; 201(12):1788-95. PubMed ID: 20446848
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study.
Bjerk SM; Baker JV; Emery S; Neuhaus J; Angus B; Gordin FM; Pett SL; Stephan C; Kunisaki KM;
PLoS One; 2013; 8(2):e56249. PubMed ID: 23457535
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.
Palella FJ; Gange SJ; Benning L; Jacobson L; Kaplan RC; Landay AL; Tracy RP; Elion R
AIDS; 2010 Jul; 24(11):1657-65. PubMed ID: 20588104
[TBL] [Abstract][Full Text] [Related]
7. Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial.
Ghazi L; Baker JV; Sharma S; Jain MK; Palfreeman A; Necsoi C; Murray DD; Neaton JD; Drawz PE
Am J Hypertens; 2020 Jan; 33(1):43-52. PubMed ID: 31800000
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results.
Kumar P; DeJesus E; Huhn G; Sloan L; Small CB; Edelstein H; Felizarta F; Hao R; Ross L; Stancil B; Pappa K; Ha B;
BMC Infect Dis; 2013 Jun; 13():269. PubMed ID: 23741991
[TBL] [Abstract][Full Text] [Related]
9. Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.
Grund B; Baker JV; Deeks SG; Wolfson J; Wentworth D; Cozzi-Lepri A; Cohen CJ; Phillips A; Lundgren JD; Neaton JD;
PLoS One; 2016; 11(5):e0155100. PubMed ID: 27171281
[TBL] [Abstract][Full Text] [Related]
10. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.
Boulware DR; Hullsiek KH; Puronen CE; Rupert A; Baker JV; French MA; Bohjanen PR; Novak RM; Neaton JD; Sereti I;
J Infect Dis; 2011 Jun; 203(11):1637-46. PubMed ID: 21592994
[TBL] [Abstract][Full Text] [Related]
11. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
Nordell AD; McKenna M; Borges ÁH; Duprez D; Neuhaus J; Neaton JD; ;
J Am Heart Assoc; 2014 May; 3(3):e000844. PubMed ID: 24870935
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: results from the Strategies for Management of Antiretroviral Therapy study.
Soliman EZ; Prineas RJ; Roediger MP; Duprez DA; Boccara F; Boesecke C; Stephan C; Hodder S; Stein JH; Lundgren JD; Neaton JD
J Electrocardiol; 2011; 44(6):779-85. PubMed ID: 21145066
[TBL] [Abstract][Full Text] [Related]
13. Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease.
Ledwaba L; Tavel JA; Khabo P; Maja P; Qin J; Sangweni P; Liu X; Follmann D; Metcalf JA; Orsega S; Baseler B; Neaton JD; Lane HC;
PLoS One; 2012; 7(3):e24243. PubMed ID: 22448211
[TBL] [Abstract][Full Text] [Related]
14. Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers.
Borges ÁH; Silverberg MJ; Wentworth D; Grulich AE; Fätkenheuer G; Mitsuyasu R; Tambussi G; Sabin CA; Neaton JD; Lundgren JD; ; ;
AIDS; 2013 Jun; 27(9):1433-41. PubMed ID: 23945504
[TBL] [Abstract][Full Text] [Related]
15. Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection.
Baker JV; Neuhaus J; Duprez D; Kuller LH; Tracy R; Belloso WH; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Nixon DE; Paton NI; Neaton JD;
J Acquir Immune Defic Syndr; 2011 Jan; 56(1):36-43. PubMed ID: 20930640
[TBL] [Abstract][Full Text] [Related]
16. The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study.
De Luca A; de Gaetano Donati K; Colafigli M; Cozzi-Lepri A; De Curtis A; Gori A; Sighinolfi L; Giacometti A; Capobianchi MR; D'Avino A; Iacoviello L; Cauda R; D'Arminio Monforte A
BMC Infect Dis; 2013 Sep; 13():414. PubMed ID: 24004495
[TBL] [Abstract][Full Text] [Related]
17. Relationship between inflammatory and coagulation biomarkers and cardiac autonomic function in HIV-infected individuals.
Young LC; Roediger MP; Grandits G; Baker J; Somboonwit C; Williams I; Lundgren JD; Neaton JD; Soliman EZ
Biomark Med; 2014; 8(9):1073-83. PubMed ID: 25402578
[TBL] [Abstract][Full Text] [Related]
18. D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events.
Freiberg MS; Bebu I; Tracy R; So-Armah K; Okulicz J; Ganesan A; Armstrong A; O'Bryan T; Rimland D; Justice AC; Agan BK;
PLoS One; 2016; 11(4):e0152588. PubMed ID: 27088215
[TBL] [Abstract][Full Text] [Related]
19. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection.
Wilson EM; Singh A; Hullsiek KH; Gibson D; Henry WK; Lichtenstein K; Önen NF; Kojic E; Patel P; Brooks JT; Sereti I; Baker JV;
J Infect Dis; 2014 Nov; 210(9):1396-406. PubMed ID: 24813472
[TBL] [Abstract][Full Text] [Related]
20. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.
Rodger AJ; Fox Z; Lundgren JD; Kuller LH; Boesecke C; Gey D; Skoutelis A; Goetz MB; Phillips AN;
J Infect Dis; 2009 Sep; 200(6):973-83. PubMed ID: 19678756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
